Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 9

Results For "South-Africa"

122 News Found

Mandaviya launches BRICS vaccine R&D centre
Policy | March 22, 2022

Mandaviya launches BRICS vaccine R&D centre

The Centre will be instrumental in streamlining vaccination resources and facilitate equitable access to safe and efficacious COVID-19 vaccines


Augnito.ai offers new features to woo doctors to its platform
Startup | March 21, 2022

Augnito.ai offers new features to woo doctors to its platform

Augnito in association with Japanese company Fujifilm enables voice recognition within their radiology information system platform


Bharat Biotech and Biofabri to develop and distribute novel TB vaccine
News | March 16, 2022

Bharat Biotech and Biofabri to develop and distribute novel TB vaccine

MTBVAC is a global public-private project that will be a milestone in the field of vaccinology


Omicron sublineage BA.2 a Variant of Concern: WHO
News | February 23, 2022

Omicron sublineage BA.2 a Variant of Concern: WHO

As part of its on-going work to track variants, WHO's Technical Advisory Group on SARS-CoV-2 Virus Evolution (TAG-VE) discussed the latest evidence on the Omicron variant of concern


WHO establishes biomanufacturing training hub in South Korea
News | February 23, 2022

WHO establishes biomanufacturing training hub in South Korea

Bangladesh, Indonesia, Pakistan, Serbia and Vietnam to receive mRNA technology from the technology transfer hub


Caplin Point’s Q3 in line; outlook positive amid expansion plans: ICICI Direct
News | February 07, 2022

Caplin Point’s Q3 in line; outlook positive amid expansion plans: ICICI Direct

Key takeaways of recent quarter & conference call highlights


Windlas Biotech concludes SAHPRA audit with an all-clear sign
News | February 02, 2022

Windlas Biotech concludes SAHPRA audit with an all-clear sign

It will enable the company to branch out to new geographies and strengthen its presence in South Africa


Cipla has strong traction in India and the US: ICICI Direct
News | January 31, 2022

Cipla has strong traction in India and the US: ICICI Direct

ICICI Direct’s analysis of Cipla’s Q3FY22 results


Cipla’s Q3FY22 PAT at Rs 729 cr.
News | January 26, 2022

Cipla’s Q3FY22 PAT at Rs 729 cr.

Cipla announced its unaudited consolidated financial results for quarter ended December 31st, 2021.


Lannett receives USFDA safety review for biosimilar insulin glargine
Biotech | January 22, 2022

Lannett receives USFDA safety review for biosimilar insulin glargine

Go-ahead for pivotal clinical trial which is expected to commence by March